MARKET

INCR

INCR

Intercure Ltd.
NASDAQ
0.8800
+0.0414
+4.94%
After Hours: 0.8800 0 0.00% 16:10 02/20 EST
OPEN
0.8400
PREV CLOSE
0.8386
HIGH
0.8800
LOW
0.8152
VOLUME
160.36K
TURNOVER
--
52 WEEK HIGH
1.770
52 WEEK LOW
0.6800
MARKET CAP
48.12M
P/E (TTM)
-2.1680
1D
5D
1M
3M
1Y
5Y
1D
InterCure Posts Higher 2025 Revenue and EBITDA, Resumes Nir Oz Output and Advances Expansion Plans
TipRanks · 1d ago
InterCure reports preliminary FY25 revenue NIS 265M
TipRanks · 1d ago
InterCure Posts Preliminary NIS 265M Revenue For 2025, An 11% YoY Rise, With 2H Revenue Nearly 20% Higher Than Prior Year
Benzinga · 1d ago
InterCure posts FY 2025 revenue of ILS 265 million, up 11%
Reuters · 1d ago
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
Barchart · 1d ago
Weekly Report: what happened at INCR last week (0209-0213)?
Weekly Report · 4d ago
Weekly Report: what happened at INCR last week (0202-0206)?
Weekly Report · 02/09 09:19
Weekly Report: what happened at INCR last week (0126-0130)?
Weekly Report · 02/02 09:19
More
About INCR
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Webull offers InterCure Ltd stock information, including NASDAQ: INCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INCR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INCR stock methods without spending real money on the virtual paper trading platform.